PATENT CLAIM ANALYSIS

Application Number: 16206961
Application Type: Utility
Filing Date: 2018-11
Publication Date: 2019-07
Patent Classification: ["424", "146100"]

Abstract:
Methods for treating cancers, such as breast cancer or skin cancer, using an ACE or ARB, or a combination of celecoxib and olmesartan.

Claim (Index 8):
The method of  claim 6 , wherein administering the therapeutically effective amount of olmesartan and celecoxib comprises administering a fixed dose combination comprising olmesartan and celecoxib.

Metadata:
- Claim Count in Document: 32.0
- Percentile: 98.0
- Lexical Diversity: 1.22727
- Patent Class: 424.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['15063000', '15402990', '14777160', '14809859', '11273992']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7116450083397003
- 35 USC 102 Novelty (BERT): 0.5024786124113918
- Combined Prediction Score: 0.6907283687468696
- Mean Citation Score: 206.032748
- Max Citation Score: 232.0479
- Similarity Product: 147.82053448580504

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test